Matches in Wikidata for { <http://www.wikidata.org/entity/Q64173368> ?p ?o ?g. }
Showing items 1 to 46 of
46
with 100 items per page.
- Q64173368 description "assaig clínic" @default.
- Q64173368 description "clinical trial" @default.
- Q64173368 description "clinical trial" @default.
- Q64173368 description "clinical trial" @default.
- Q64173368 description "clinical trial" @default.
- Q64173368 description "ensaio clínico" @default.
- Q64173368 description "ensayo clínico" @default.
- Q64173368 description "ensayu clínicu" @default.
- Q64173368 description "essai clinique" @default.
- Q64173368 description "klinisch onderzoek" @default.
- Q64173368 description "клінічне випробування" @default.
- Q64173368 description "կլինիկական փորձարկում" @default.
- Q64173368 name "Talimogene Laherparepvec in Combination With Neoadjuvant Chemotherapy in Triple Negative Breast Cancer" @default.
- Q64173368 type Item @default.
- Q64173368 label "Talimogene Laherparepvec in Combination With Neoadjuvant Chemotherapy in Triple Negative Breast Cancer" @default.
- Q64173368 prefLabel "Talimogene Laherparepvec in Combination With Neoadjuvant Chemotherapy in Triple Negative Breast Cancer" @default.
- Q64173368 P1050 Q64173368-CEC550CA-768E-42BB-8C92-73665C05677B @default.
- Q64173368 P1132 Q64173368-D854DFE7-EE86-4715-B24F-E91CDB34CDE2 @default.
- Q64173368 P1476 Q64173368-3DF81235-1F32-407D-B285-C38601180E2D @default.
- Q64173368 P17 Q64173368-A158B701-8523-4908-ACEF-1B2CB7D0412C @default.
- Q64173368 P2899 Q64173368-6D78D0BF-3510-42BA-877E-9E844BA177FF @default.
- Q64173368 P3098 Q64173368-4A79EC0F-27D8-46D9-B92C-8F2DCC4E4493 @default.
- Q64173368 P31 Q64173368-3A3FF719-314E-4428-BCCD-9242FC427036 @default.
- Q64173368 P4135 Q64173368-AB3204CA-7D87-4D35-9ABA-A9B4BDA1F409 @default.
- Q64173368 P4844 Q64173368-2C5A3A7E-E0BD-4A46-B6E2-B491D8FAF322 @default.
- Q64173368 P4844 Q64173368-83F081B8-2E3C-4C18-B7E6-BB0D8712FEFE @default.
- Q64173368 P580 Q64173368-FF0D2AD9-7589-46D6-A173-911782FECAA6 @default.
- Q64173368 P582 Q64173368-A594C427-D840-459B-B2BD-03727F54C3D0 @default.
- Q64173368 P6099 Q64173368-3E5BCE34-A166-40FE-BD3F-46F635B433E2 @default.
- Q64173368 P6099 Q64173368-5343AE44-0C8E-4DFD-8723-D6A047338107 @default.
- Q64173368 P8363 Q64173368-ABA15E23-A803-4526-9AE5-B1440591770C @default.
- Q64173368 P1050 Q33525 @default.
- Q64173368 P1132 "+46" @default.
- Q64173368 P1476 "A Phase 1/2 Study of Talimogene Laherparepvec in Combination With Neoadjuvant Chemotherapy in Triple Negative Breast Cancer" @default.
- Q64173368 P17 Q30 @default.
- Q64173368 P2899 "+18" @default.
- Q64173368 P3098 "NCT02779855" @default.
- Q64173368 P31 Q30612 @default.
- Q64173368 P4135 "+70" @default.
- Q64173368 P4844 Q423762 @default.
- Q64173368 P4844 Q7679524 @default.
- Q64173368 P580 "2017-03-22T00:00:00Z" @default.
- Q64173368 P582 "2021-08-31T00:00:00Z" @default.
- Q64173368 P6099 Q42824440 @default.
- Q64173368 P6099 Q5452194 @default.
- Q64173368 P8363 Q78089383 @default.